Innovative therapeutics for neuro diseases
The concept of Anandelix has been developed over several years with numerous contributions.
Growth and neural connectivity
The concept of Anandelix has been developed over several years with numerous contributions. It centers around the idea that certain substances, like natural tryptamines, induce neuroplasticity in ways beyond changes in cognitive perception of ego self-representation. These compounds have the potential to restore healthy brain structures, offering therapeutic benefits for both mood disorders (software) and neurological diseases (hardware).
The company aims to modulate neurogenesis and neuroplasticity, promoting the development of new healthy neurons, enhancing existing ones, and restoring healthy neuronal activity in damaged brain areas.
The Business Consulting Process
On the scientific front, research conducted by different investigative centers continues to support their central thesis that therapeutic neuroplasticity can be achieved with this class of compounds. Meanwhile, their research team is advancing studies with these substances in animal models and humans.
Revolutionizing Neurological Therapies
To launch of Anandelix, an early-stage therapeutic company focused on developing innovative treatments for neurological diseases. Progress made by the FDA in clinical trials involving substances like MDMA and psilocybin for mood disorders indicates growing acceptance of these new therapeutic applications. Moreover, specific regions and countries, such as Oregon and Australia, have taken steps towards establishing frameworks for their use.
Scientific research conducted by various investigative centers continues to support Anandelix’s central thesis that therapeutic neuroplasticity can be achieved through the use of specific compounds. The company’s research team is actively advancing studies using these substances in animal models and human subjects.
focus on explore the potential of psychoplasticogens and their role in promoting neuroplasticity
progress in research and clinical trials that validate the effectiveness of our innovative treatments in neurological diseases.
our groundbreaking treatments are offering new hope for patients with neurological diseases, ranging from strokes to mood disorders.
a team of talented professionals, cutting-edge laboratory facilities, and strategic partnerships for research outsourcing.
Our Partners
The industry is the establishment of clear regulatory and licensing requirements for controlled substances. This has helped streamline the process of obtaining necessary approvals and authorizations for their research, which, in turn, has accelerated their preclinical approval timeline.
